Abstract: Systems and methods are described for generating electricity from fluid produced from a subsurface formation. The disclosed systems and methods include generating electrical power using the energy content of fluids produced from the earth or hot fluids created during surface processing of the produced fluids. Fluid is obtained from a well in the subsurface formation and provided to a first power generation device where a pressure and a temperature of the fluid is adjusted to a pressure and a temperature compatible with the first power generation device using one or more valves coupled to the first power generation device. The first power generation device generates electricity from the fluid. One or more second power generation devices also generate electricity using the fluid where one of the second power generation devices is a thermoelectric generator.

Abstract: A method may include obtaining a trained machine learning (ML) pipeline skeleton model configured to predict functional blocks within a new ML pipeline based on meta-features of a dataset associated with the new ML pipeline; obtaining parametric templates, each of the parametric templates including fillable portions and static text portions that in combination describe a given functional block; receiving a request to generate the new ML pipeline; determining functional blocks to populate the new ML pipeline based on the pipeline skeleton model; extracting decision-making conditions leading to the functional blocks; generating explanations of the functional blocks using the parametric templates, where at least one of the fillable portions is filled based on the decision-making conditions leading to the functional blocks; instantiating the new ML pipeline including the functional blocks with the generated explanations.

Abstract: Multi-site distributed storage systems and computer-implemented methods are described for providing an automatic unplanned failover (AUFO) feature to guarantee non-disruptive operations (e.g., operations of business enterprise applications, operations of software application) even in the presence of failures including, but not limited to, network disconnection between multiple data centers and failures of a data center or cluster.

Abstract: A system and method include migrating, by a migration controller, a first entity of a first subset of entities from a source site to a target site in a virtual computing system based on an asynchronous mode of replication. The system and method also include replicating, by the migration controller, data of a second entity of a second subset of entities from the source site to the target site based on a synchronous mode of replication in parallel with the migration of the first entity for dynamically adjusting a recovery time objective parameter.

Abstract: Systems and methods for configuration driven integration of services in business process models agnostic of a workflow system are disclosed. An exemplary method includes receiving, at a service executor, a generic service call from a business process management notation (BPMN), wherein the generic service call includes a service name parameter, wherein the service name parameter is associated with a service task of the BPMN, and wherein the service name parameter is associated with a service. The service executor can construct a call to the service including required data from a transient data store. The service executor can then receive return data from the service, store the data in the transient data store and respond to the BPMN that the service task has been completed.

Abstract: There is provided a dose counter assembly for use with a medicament dispenser, the dose counter assembly comprising: a) a units dose display means comprising a first count indicia and one or more driver teeth; b) a tens dose display means comprising a second count indicia; and c) a driver, wherein the first count indicia and second count indicia align at a common viewing area to collectively display a count sequence.

Abstract: Systems and methods are described for producing lithium hydroxide from lithium chloride and sodium chloride through an electrolysis process. A solution of lithium hydroxide and sodium hydroxide may be produced through electrolysis of a lithium chloride and sodium chloride solution. Lithium hydroxide in the produced solution may then be crystallized and filtered out to produce substantially pure lithium hydroxide crystals.

Abstract: Operations may include obtaining a repair related to correcting an error of source code of a software program, the repair including an edit to make to the source code. The operations may further include determining a change type of the edit. The operations may additionally include identifying an explanation template from a library of explanation templates based on the change type corresponding to the explanation template in the library of explanation templates. In addition, the operations may include generating a change explanation for the edit based on the explanation template. The change explanation may provide a natural language explanation of the changes made by the edit.

Abstract: The present invention provides therapeutic compound for prevention and treatment of primary biliary cholangitis, (PBC). Specifically, the present invention provides pharmaceutical composition comprising a compound of Formula (I) or a pharmaceutically acceptable salt thereof, for the treatment of PBC.

Abstract: A method and system for providing location services at a network edge is described. An AP can receive location information associated with a second AP in a location group. The AP can also receive client location data from the second AP and associated with a first client. From at least the received client location data, the AP can determine a location of the first client. The AP can then send the location of the first client to a location service.

Abstract: A method of data input via a user interface is described. According to the method, a set of input fields may be provided at the user interface which correspond to respective columns or to respective rows of a data table. A data input may be received at the user interface within an input field of the set of input fields which corresponds to a first column or to a first row of the data table. An applicability indication may then be received at the user interface which indicates that the data input is applicable to a subset of the rows or a subset of the columns. Based on receiving the data input within the input field and based on the applicability indication, multiple instances of the data input may be applied to the data table.

Abstract: Present invention relates to development of prolyl hydroxylase inhibitor for treatment of Psoriasis and skin inflammatory diseases. Specifically, invention relates to development of compound of formula (Ia) for treatment of Psoriasis and skin inflammatory diseases. Invention also relates to pharmaceutical composition comprising compound of formula (Ia) for treatment of Psoriasis and skin inflammatory diseases.

Abstract: Present invention relates to development of compound of formula (Ia) for treatment of inflammatory bowel diseases. Invention also relates to pharmaceutical composition comprising therapeutically effective compound of formula (Ia) for treatment of inflammatory bowel diseases.

Abstract: Multi-site distributed storage systems and computer-implemented methods are described for providing an automatic unplanned failover (AUFO) feature to guarantee non-disruptive operations (e.g., operations of business enterprise applications, operations of software application) even in the presence of failures including, but not limited to, network disconnection between multiple data centers and failures of a data center or cluster.

Abstract: Methods of semiconductor processing may include performing a first plasma treatment within a processing chamber to remove a first carbon-containing material. The methods may include performing a second plasma treatment within the processing chamber to remove a first silicon-containing material. The methods may include depositing a second silicon-containing material on surfaces of the processing chamber. The methods may include depositing a second carbon-containing material overlying the second silicon-containing material.

Abstract: Various implementations disclosed herein include devices, systems, and methods that adjusts operating modes for generating three-dimensional (3D) representations of a physical environment. For example, an example process may include acquiring sensor data by the one or more sensors in a physical environment and operating the device according to a first operating mode and a second operating mode during different periods of time. In the first operating mode (e.g., discovery mode), the device generates a 3D representation of the physical environment based on the sensor data and the device monitors one or more conditions to switch to the second operating mode. In the second operating mode (e.g., monitoring mode), the device monitors the one or more conditions to switch to the first operating mode and generates the 3D representation differently than the first operating mode.

Abstract: During positioning of a user equipment (UE), for example, during an emergency call, a civic location of the UE may be determined. For example, during a location session in a wireless network, a UE may detect a WiFi access point (AP) and obtain the civic location of the WiFi AP from the AP. The UE may provide the civic location to a location server in the wireless network, which may treat the civic location as the civic location of the UE. The location server may validate the civic location using a geodetic location, e.g., obtained based on measurements from a satellite positioning system and/or base stations in the wireless network. The location server may further verify that the UE is proximate to the WiFi AP using WiFi positioning measurements performed by the UE. The validated civic location can be provided to an external client, e.g. a PSAP.

Abstract: The present invention provides therapeutic compound for prevention and treatment of primary biliary cholangitis, (PBC). Specifically, the present invention provides pharmaceutical composition comprising a compound of Formula (I) or a pharmaceutically acceptable salt thereof, for the treatment of PBC.

Abstract: Described embodiments provide systems and methods for tunneling data packets to a server. A computing device can include a processor and a network interface. The processor is configured to execute a network service, a local application, and a virtual private network (VPN) application. The network service can receive a packet from the local application for transmission via a VPN tunnel, the packet comprising a source address of the computing device and a source port associated with the local application. The network service can determine that the packet matches a first tunnel filter. The network service can encapsulate, responsive to the determination that the packet matches the first tunnel filter, the packet with the header comprising a localhost destination address and a destination port associated with the VPN application. The network service can provide the encapsulated packet to the VPN application.

Abstract: The present invention provides a method for the treatment of DLL3-positive cancer or SCLC, comprising administering to a subject in need thereof an anti-DLL3 agent at a dose of between about 0.3 mg to about 100 mg or between about 3 mg to about 200 mg, once every two weeks. Step dosing of the anti-DLL3 agent for the treatment of SCLC is also disclosed.